HCAT - Health Catalyst Inc. (HCAT) Q4 2023 Earnings Call Transcript
2024-02-22 23:49:09 ET
Health Catalyst, Inc. (HCAT)
Q4 2023 Earnings Conference Call
February 22, 2024 17:00 ET
Company Participants
Adam Brown - Senior Vice President, FP&A and Investor Relations
Dan Burton - Chief Executive Officer
Bryan Hunt - Chief Financial Officer
Conference Call Participants
Anne Samuel - JPMorgan
Stephanie Davis - Barclays
Jared Haase - William Blair
Sameer Patel - Evercore ISI
Daniel Grosslight - Citi
David Larsen - BTIG
Sarah James - Cantor Fitzgerald
Vishal Patel - Piper Sandler
John Pinney - Canaccord Genuity
Presentation
Operator
Welcome to the Health Catalyst’s Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Adam Brown, Senior Vice President of FP&A and Investor Relations. Please go ahead, sir.
Adam Brown
Good afternoon, and welcome to Health Catalyst’s earnings conference call for the fourth quarter of 2023, which ended on December 31, 2023. My name is Adam Brown. I am the Senior Vice President of Investor Relations and Financial Planning and Analysis for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; and Bryan Hunt, our Chief Financial Officer.
A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com. As a reminder, today’s call is being recorded, and a replay will be available following the conclusion of the call.
During today’s call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding trends, strategies, the impact of the macroeconomic challenges, including the impact of inflation and the interest rate environment, the tight labor market, our pipeline conversion rates and the general anticipated performance of our business. These forward-looking statements are based on management’s current views and expectations as of today and should not be relied upon as representing our views as of any subsequent date. We disclaim any obligation to update any forward-looking statements or outlook. Actual results may materially differ.
Please refer to the risk factors in our Form 10-Q for Q3 2023 filed with the SEC on November 6, 2023, and our Form 10-K for the full year 2023 that will be filed with the SEC. We will also refer to certain non-GAAP financial measures to provide additional information to investors. A reconciliation of these non-GAAP financial measures to their most comparable GAAP measures is provided in our press release....
Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript